-
QUESTION
how convincing is the scientific evidence that nuts decreased the risk of cardiovascular disease or the risk of death from cardiovascular
word limit 500
everything is described in details in the attached documents below.
everything needed is in the document below, please read carefully, no additional sources are needed, use the abstracts given in the document, and no other researches are required. Just read the documents <020-9-NFS284-Essay.pdf> for this short essay
| Subject | Nursing | Pages | 4 | Style | APA |
|---|
Answer
-
-
Impact of Nuts Intake on Cardiovascular Diseases.
Cardiovascular diseases refer to various conditions that arise due to the blockage of blood vessels after the development of atherosclerosis (Appendix 1). Common cardiovascular diseases (CVD) include Ischemic Heart disease, Coronary Heart disease, Coronary artery disease, and Myocardial Infarction. Often, Myocardial Infarction, commonly known as heart attack, is the most prevalent CVD. Notably, the blockage of the blood vessels can be in the heat or brain. As such, CVD refers to illnesses that affect both the heart and the brain. An underlying preconception about CVD is that nuts' consumption can lower the risk factors of these diseases or reduce the propensity of dying from CVD.
Nuts are divided into tree nuts and peanuts. Primarily, peanuts are not considered tree nuts but have a similar nutritional composition as tree nuts. Consumption of nuts can lower the risk of all CVDs by about 14% and about 15% for Coronary heart disease. The impact is mainly due to the high fatty acid composition of nuts. Notably, nuts have a high content of folate, magnesium, and monounsaturated fatty acids (MUFA) (Um & He, 2011). Thus, the consumption of nuts, which translates to a high intake of polyunsaturated fatty acids and MUFA, reduces Triacylglycerol (TAG), which is a leading risk factor for CVD.
Nouran et al.'s (2010) randomized crossover clinical trial compares the impact of consuming peanuts with another diet on a person's susceptibility to CVDs. From the results obtained, the consumption of peanuts resulted in improved chances of not getting CVDs. Ideally, the statistical difference in reducing risk factors for CVD between consuming peanuts and other diet was depicted in measures for body weight, blood pressure, and two elements of blood cholesterol. Notably, the P-value was over 0.1, indicating a significant impact of peanut on reducing the risk of cardiovascular diseases.
Guasch-Ferré et al. (2017) study the relationship between the intake of different nut and the various CVDs. In this regard, the relative risk of contracting cardiovascular illness when not taking any nuts is one that represents a high risk. However, taking any form of nuts at least once a week reduces the relative risk by about 0.1 percent. On the other hand, maintaining a trend of taking nuts reduces the relative risk for CVDs to 0.0002. Almost similar findings are realized when the types of nuts are varied, indicating that both peanuts, tree nuts, peanut butter, and walnuts significantly reduce the risk of contracting any cardiovascular illnesses when taken regularly.
Luu et al. (2015) evaluate the cause-specific mortality involving cardiovascular illness and how nuts' intake impacts them. In this regard, utilizing food validated frequency, Luu et al. (2015) found that the lowest intake of nuts results in the highest mortality rates from CVD. However, the high frequency of consuming nuts leads to a significant reduction of mortality incidences related to CVDs.
From the evaluation in the four articles, it is apparent that peanuts reduce the risk of cardiovascular diseases and mortality risk from CVD. Notably, the articles utilize scientific approaches to carry out their studies, thereby making them convincing. Moreover, primary research is carried out in all studies, which enhances their evidence level. Consequently, the articles are either level one or level two, which indicates high validity and reliability. As such, the scientific evidence presented in Appendix 1 articles is highly convincing that nuts decreased the risk of cardiovascular diseases or the risk of death.
-
References
-
-
Guasch-Ferré, M., Liu, X., Malik, V. S., Sun, Q., Willett, W. C., Manson, J. E., & Bhupathiraju, S. N. (2017). Nut consumption and risk of cardiovascular disease. Journal of the American College of Cardiology, 70(20), 2519-2532.
Luu, H. N., Blot, W. J., Xiang, Y. B., Cai, H., Hargreaves, M. K., Li, H., ... & Shu, X. O. (2015). Prospective evaluation of the association of nut/peanut consumption with total and cause-specific mortality. JAMA internal medicine, 175(5), 755-766.
Nouran, M. G., Kimiagar, M., Abadi, A., Mirzazadeh, M., & Harrison, G. (2010). Peanut consumption and cardiovascular risk. Public health nutrition, 13(10), 1581-1586.
Um, C. Y., & He, K. (2011). Long-term walnut supplementation without dietary advice induces favorable serum lipid changes in free-living individuals. European journal of clinical nutrition, 65(3), 421-421.
-
Related Samples
[/et_pb_text][et_pb_divider color="#E02B20" divider_weight="2px" _builder_version="4.9.3" _module_preset="default" width="10%" module_alignment="center" custom_margin="|||349px||"][/et_pb_divider][/et_pb_column_inner][/et_pb_row_inner][et_pb_row_inner use_custom_gutter="on" _builder_version="4.9.3" _module_preset="default" custom_margin="|||-44px||" custom_margin_tablet="|||0px|false|false" custom_margin_phone="" custom_margin_last_edited="on|tablet" custom_padding="13px||16px|0px|false|false"][et_pb_column_inner saved_specialty_column_type="3_4" _builder_version="4.9.3" _module_preset="default"][et_pb_blog fullwidth="off" post_type="project" posts_number="5" excerpt_length="26" show_more="on" show_pagination="off" _builder_version="4.9.3" _module_preset="default" header_font="|600|||||||" read_more_font="|600|||||||" read_more_text_color="#e02b20" width="100%" custom_padding="|||0px|false|false" border_radii="on|5px|5px|5px|5px" border_width_all="2px" box_shadow_style="preset1"][/et_pb_blog][/et_pb_column_inner][/et_pb_row_inner][/et_pb_column][et_pb_column type="1_4" _builder_version="3.25" custom_padding="|||" custom_padding__hover="|||"][et_pb_sidebar orientation="right" area="sidebar-1" _builder_version="4.9.3" _module_preset="default" custom_margin="|-3px||||"][/et_pb_sidebar][/et_pb_column][/et_pb_section][et_pb_section fb_built="1" specialty="on" _builder_version="4.9.3" _module_preset="default" custom_padding="0px|0px|0px|||"][et_pb_column type="3_4" specialty_columns="3" _builder_version="3.25" custom_padding="|||" custom_padding__hover="|||"][et_pb_row_inner _builder_version="4.9.3" _module_preset="default" custom_margin="|||-44px|false|false" custom_margin_tablet="|||0px|false|false" custom_margin_phone="" custom_margin_last_edited="on|tablet" custom_padding="28px|||||"][et_pb_column_inner saved_specialty_column_type="3_4" _builder_version="4.9.3" _module_preset="default"][et_pb_text _builder_version="4.9.3" _module_preset="default"]- QUESTION
Week 4 Discusssion
Choose ONE of the following discussion question options to respond to: Using Adverse Conditions to a Company's AdvantageThis is a discussion question that I need answered. I need the second portion of the questioned answered thoroughly, both bullet points. I have highlighted it in yellow to show that it is what I need answered. I need this r returned to me completed without any grammatical or punctual errors. The company that I want this question written about is Nissan Motor Corporation. - Chakravorti (2010) discusses four methods that corporate innovators use to turn adverse conditions to their advantage. Examine an organization of your choice and briefly discuss how the organization might use one of these methods.
- Using the company of your choice, identify an important and difficult decision that they faced. What were the most important risks and the most important rewards of the decision?
- What data, analysis or perspective would you have used to help Sr. Management decide if the rewards outweighed the risks?
| Subject | Business | Pages | 4 | Style | APA |
|---|
Answer
Assessing Risk and Reward
The Nissan Motor Company is one of the leading automobile makers in the world. The Japanese carmaker has primarily enjoyed a successful run, allowing it to enter various regional and international markets such as the United States. However, the changing business environment was not favorable to the company in 2019. Notably, the cooperation recorded losses amounting to 7.8%. The experience pushed the management into making tough decisions, requiring almost all of its North American workforce to go for unpaid leaves.
In late 2019, the company announced that the decline in sales necessitated a two-day unpaid leave for the North American workers. The stated days for the vacation were January 2 and 3rd (Chicago Tribune, 2019). Notably, this move was a crucial decision for the company because of its conflicting impacts. Whereas on the positive side, it could help the firm minimize expenses, it threatened to affect the public perception of the company regarding employee welfare.
The rewards for the decision involved cutting expenses by not paying the workers on leave, which eventually would translate into reduced expenses. Another reward was that the decision could allow the company to optimize performance by evaluating employee performances then developing new milestones. However, on the low side, the company risked affecting its public image and brand name, especially in the North American market. As per Chakravorti (2010), the way an organization treats its employees influences the firm's public perception. Thus, Nissan risked eliciting a negative public perception. With a distorted public image, the company could fail to revive its declining sales.
I would have advised the management of Nissan to utilize the Predictive Analytic perspective in determining the right decision to take. Ideally, the approach tries to predict what might happen in the future if particular decisions or actions are undertaken at the moment (Traymbak & Aggarwal, 2019). Looking at the situation at Nissan, the company needed to develop a goal such as increasing sales. After that, they would have made decisions aimed at realizing the set goal. In this regard, the predicted outcome could give the management an overview of whether more risks existed or significant rewards could be realized.
.
References
-
Choudhry, Saad A, Muhammad Jahanzaib Anwar, Muhammad Afzal, and Abdul Shah. “Foodborne Botulism, I Only Had Nacho Cheese: A Case Report.” Cureus vol. 9, no. 9 e1666. 8 Sep. 2017, pp. 1-16. DOI:10.7759/cureus.1666
Fung, Hin Tat, Ka Man Chan, and Shing Kit Tommy Lam. “A review of iatrogenic botulism.” Hong Kong Journal of Emergency Medicine, vol. 27, no. 6, 2020, pp. 356-367. https://doi.org/10.1177%2F1024907920934901
Hellmich, Dorothea, Katja E. Wartenberg, Stephan Zierz, and Tobias J. Mueller. “Foodborne botulism due to ingestion of home-canned green beans: two case reports.” Journal of Medical Case Reports, vol. 12, Article number: 1, 2018. https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-017-1523-9
Jeffery, Lain. “Botulism.” StatPearls, 2020. https://www.ncbi.nlm.nih.gov/books/n/statpearls/article-18469
Kanaan, Manal Hadi Ghaffoori and Ahmad M. Tarek. “Clostridium botulinum, a foodborne pathogen and its impact on public health.” Annals of Tropical Medicine and Public Health, vol. 23, no. 5, 2020, pp. 49-62. DOI: 10.36295/ASRO.2020.2357.
Kryzowska-Firych, Joanna, Anna Miklaszewska, and Krzysztof Tomasiewicz. “Foodborne botulism in eastern Poland: a hospital-based retrospective study and epidemiological data review.” International Journal of Food Properties, vol. 23, no. 1, 2020, pp. 609-615. https://doi.org/10.1080/10942912.2020.1749065
Lonati, Davide, Azzurra Schicchi, Marta Crevani, Eleonora Buscaglia, Giulia Scaravaggi, Francesca Maida, Marco Cirronis, Valeria Margherita Petrolini, and Carlo Alessandro Locatelli. “Foodborne Botulism: Clinical Diagnosis and Medical Treatment.” Toxins vol. 12, no. 8. 7 Aug. 2020, pp. 1-81. DOI: 10.3390/toxins12080509
Rasetti-Escargueil, Christine, Emmanuel Lemichez, and Michel R. Popoff. “Public Health Risk Associated with Botulism as Foodborne Zoonoses.” Toxins vol. 12, 1. 30 Dec. 2019, pp. 1-119. DOI: 10.3390/toxins12010017.
Tamrin, Mohd IslahuddinMohd. “The dilemma of diagnosing wound botulism in an infant: A rare case of paralysis with topical application of honey.” International Journal of Infectious Diseases, vol. 95, 2020, pp. 157-159. https://www.sciencedirect.com/science/article/pii/S1201971220301764
Tiwari, Aman. “Clostridium Botulinum.” StatPearls, 2020. https://www.ncbi.nlm.nih.gov/books/n/statpearls/article-19635